Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Renatus

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Biochemistry|November 14, 1997
Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavageM Renatus, M T Stubbs, R Huber, et al.
The Journal of Biological Chemistry|August 29, 1997
Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitorsM Renatus, W Bode, R Huber, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
Structural basis for the activation of human procaspase-7S J Riedl, P Fuentes-Prior, M Renatus, et al.
Cell|March 21, 2001
Structural basis for the inhibition of caspase-3 by XIAPS J Riedl, M Renatus, R Schwarzenbacher, et al.
Structure (London, England : 1993)|July 25, 2000
Crystal structure of the apoptotic suppressor CrmA in its cleaved formM Renatus, Q Zhou, H R Stennicke, et al.
Nature|November 9, 2001
Crystal structure of the anthrax lethal factorA D Pannifer, T Y Wong, R Schwarzenbacher, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biochemistry|November 14, 1997
Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavageM Renatus, M T Stubbs, R Huber, et al.
The Journal of Biological Chemistry|August 29, 1997
Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitorsM Renatus, W Bode, R Huber, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
Structural basis for the activation of human procaspase-7S J Riedl, P Fuentes-Prior, M Renatus, et al.
Cell|March 21, 2001
Structural basis for the inhibition of caspase-3 by XIAPS J Riedl, M Renatus, R Schwarzenbacher, et al.
Structure (London, England : 1993)|July 25, 2000
Crystal structure of the apoptotic suppressor CrmA in its cleaved formM Renatus, Q Zhou, H R Stennicke, et al.
Nature|November 9, 2001
Crystal structure of the anthrax lethal factorA D Pannifer, T Y Wong, R Schwarzenbacher, et al.
Pageof 2